Finance News
Complete Finance & Business News Journal

Glenmark Pharma Q4 results: Net profit jumps 36% to Rs 220 crore


New Delhi: Glenmark Prescription drug drugs on Friday put up the 36.28 % embrace its consolidated world wide web profit to Rs 220.3 or more crore for your fourth fraction ended Walk 31, 2020.

The Mumbai-based drug organization had noted a world wide web profit of Rs 161.66 crore for the equivalent time 2018-19.

The carrier’s pick a revenue for the fraction flower 7.96 % to Rs 2,767.48 crore as towards Rs 2,563.47 crore a year ago, Glenmark Pharmaceutical prescription drugs said in a regulatory performing.

For the financial 12 months 2019-20, the company noted the consolidated net profit involving Rs 775.97 crore as against Rs 924.99 crore around 2018-19.

The company’s pick a profit for 2019-20 flower to Rs 10,640.96 crore as in opposition to Rs 98,65.46 crore recording over the past equivalent period.

“Our expansion impetus sustained in the finally fraction despite the COVID-19 outbreak plus challenging generic business enterprise setting across markets internationally,” Glenmark Pharmaceuticals Chair person plus MD Glenn Saldanha stated.

The company’s The indian subcontinent, The european countries and Latina America areas performed effectively during the fraction, he added in.

“Our continual performance continues to be due to the continual efforts of most our staff members around the world. All of our manufacturing establishments have run continuously plus facilitated often the uninterrupted availability of medicines to operating market segments,” Saldanha said.

Its board advised a gross of Rs 2.your five per talk about of a deal with value of Maest? 1 every single (250 every cent) for your financial 12 months 2019-20.

Get real time updates directly on you device, subscribe now.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Translate »